company
Immuno-Mycologics, Inc
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-05-06Immuno-Mycologics, Inc — Class II recall: Immy, Myco DDR Trident, Bulk Neutralization Buffer B (60 X 30 mL), REF: TBPN67-6…
Frequently asked questions
- How many FDA warning letters has Immuno-Mycologics, Inc received?
- Argus HQ has not recorded an FDA warning letter for Immuno-Mycologics, Inc in our current dataset.
- What FDA recalls has Immuno-Mycologics, Inc issued?
- Argus HQ has recorded 1 FDA recall tied to Immuno-Mycologics, Inc.
- Is Immuno-Mycologics, Inc FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Immuno-Mycologics, Inc. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

